Navidea Biopharmaceuticals (NAVB) Posts Q3 Loss of 9c/Share

November 6, 2013 7:31 AM

Navidea Biopharmaceuticals (NYSE: NAVB) reported Q3 loss of $0.09 per ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found